SAB Biotherapeutics Inc
NASDAQ:SABS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SAB Biotherapeutics Inc
NASDAQ:SABS
|
US |
|
A
|
Alcatel Lucent Teletas Telekomunikasyon AS
IST:ALCTL.E
|
TR |
|
Brewbilt Manufacturing Inc
OTC:BBRW
|
US |
|
F
|
FTAC Emerald Acquisition Corp
NASDAQ:EMLD
|
US |
|
R
|
RomReal Ltd
XMUN:3RR
|
BM |
|
F
|
FNS Holdings PCL
SET:FNS
|
TH |
|
Ebusco Holding NV
F:8J30
|
NL |
|
Autins Group PLC
LSE:AUTG
|
UK |
|
Yamatane Corp
TSE:9305
|
JP |
|
C
|
Cooper Energy Ltd
OTC:COPJF
|
AU |
|
S
|
Secom Co Ltd
XMUN:XSC
|
JP |
|
Candente Copper Corp
TSX:DNT
|
CA |
|
C
|
CI Group PCL
SET:CIG
|
TH |
|
ISDN Holdings Ltd
SGX:I07
|
SG |
|
K
|
Kajima Corp
XMUN:KAJ
|
JP |
|
88 Energy Ltd
OTC:EEEND
|
AU |
|
AMG Advanced Metallurgical Group NV
AEX:AMG
|
NL |
|
D
|
Dexelance SpA
MIL:DEX
|
IT |
|
Hitek Global Inc
F:4JX
|
CN |
|
C
|
CEZ as
DUS:CEZ
|
CZ |
|
S
|
SCG Packaging PCL
SET:SCGP
|
TH |
|
Tubos Reunidos SA
MAD:TRG
|
ES |
|
L
|
Lease IT PCL
SET:LIT
|
TH |
Wall St Price Targets
SABS Price Targets Summary
SAB Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for SABS is 11.87 USD with a low forecast of 6.06 USD and a high forecast of 16.8 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SABS's stock price target?
Price Target
11.87
USD
According to Wall Street analysts, the average 1-year price target for SABS is 11.87 USD with a low forecast of 6.06 USD and a high forecast of 16.8 USD.